Clinical Stock Market Invest

Psyence Biomed Details Corporate Milestones with Emphasis on Upcoming Phase II Operational Highlights Sep 16, 2024

Intelligent Bio Solutions Inc. Advances Toward FDA 510(k) Clearance with Clinical Study Progress Sep 6, 2024

AIM ImmunoTech Showcases Robust Q2 2024 Financial Performance and Shares Clinical Progress Aug 17, 2024

Athira Pharma Completes LIFT-AD Trial for Alzheimer's Treatment, Expects Results by Q3 2024 Jul 10, 2024

Ormco™ Announces Upcoming Elite Clinical Symposium for Orthodontists Jul 10, 2024

INHALE-3 Study Shows Positive Results for Inhaled Insulin in T1D Patients, Implications for MannKind Corporation Jun 23, 2024

Corbus Pharmaceuticals Reports Promising Results for SYS6002 in Nectin-4 Positive Tumor Treatment Jun 2, 2024

Athira Pharma Announces Comprehensive 2023 Financial Results and Future Growth Perspectives Feb 23, 2024

Bionomics Announces 2023 Achievements and Unveils Strategic Plan for 2024 Jan 23, 2024

Cellectar Biosciences Achieves Milestone in CNS Lymphoma with Iopofosine I 131 Jan 22, 2024

Tryp Therapeutics Targets IBS and Fibromyalgia with Psilocybin Clinical Trials Jan 9, 2024

Innovative Psychedelic Treatments for TBI Show Promise: A Look at Recent Developments Jan 8, 2024

Immix Biopharma Receives FDA Nod for CAR-T Cell Therapy IND, Eyes U.S. Treatment Commencement Nov 21, 2023

Moleculin Biotech Reports Robust Third Quarter 2023 Financials with a Strong Cash Position Nov 14, 2023

Moleculin Biotech Announces Q3 2023 Financials with Strong Cash Position and Promising Clinical Data Nov 14, 2023

Achilles Therapeutics Announces Q3 2023 Financials and Progress in Patient Dosing Nov 14, 2023